Search for a doctor

J. Eric Ahlskog, M.D., Ph.D.

  1. Neurologist
Request an Appointment

Publications

  1. Meade G, Whitwell JL, Dickson DW, Duffy JR, Clark HM, Ahlskog JE, Machulda MM, Josephs KA, Utianski RL. Primary Progressive Apraxia of Speech Caused by TDP-43: A Case Report. Neurol Genet. 2024 Apr; 10 (2):e200134 Epub 2024 Mar 19
    View PubMed
  2. Ahlskog JE. Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarks. Parkinsonism Relat Disord. 2024 Apr; 121:106037 Epub 2024 Feb 10
    View PubMed
  3. Yang B, Brown A, McKeon A, Ahlskog JE, Tipton P, Guo Y, Lucchinetti C, Pittock SJ, Zekeridou A. Tenascin-R Autoimmunity: Isolated Tremor Reversed with Immunotherapy. Ann Neurol. 2023 Sep; 94 (3):502-507 Epub 2023 July 14
    View PubMed
  4. Ahlskog JE. Levodopa, homocysteine and Parkinson's disease: What's the problem? Parkinsonism Relat Disord. 2023 Apr; 109:105357 Epub 2023 Mar 06
    View PubMed
  5. Camerucci E, Mullan AF, Bower JH, Bharucha AE, Turcano P, Stang CD, Benarroch EE, Boeve BF, Ahlskog JE, Savica R. Lifelong constipation in Parkinson's disease and other clinically defined alpha-synucleinopathies: A population-based study in Southeast Minnesota. Parkinsonism Relat Disord. 2023 Feb; 107:105244 Epub 2022 Dec 22
    View PubMed
  6. Camerucci E, Mullan AF, Turcano P, Bower J, Piat C, Ahlskog JE, Savica R. 40-Year Incidence of Early-Onset Parkinson's Disease in Southeast Minnesota. J Parkinsons Dis. 2023; 13 (6):893-898
    View PubMed
  7. Hassan A, Mittal SO, Hu WT, Josephs KA, Sorenson EJ, Ahlskog JE. Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov; 23 (7-8):554-561 Epub 2022 Feb 16
    View PubMed
  8. Carlos AF, Sekiya H, Koga S, Pham NTT, Ali F, Botha H, Clark HM, Coon EA, Lowe V, Ahlskog JE, Trejo-Lopez JA, Dickson DW, Whitwell JL, Josephs KA. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. Parkinsonism Relat Disord. 2022 Aug; 101:9-14 Epub 2022 June 16
    View PubMed
  9. Simpson HD, Duffy JR, Stierwalt JAG, Ahlskog JE, Hassan A. Speech-induced action myoclonus. Parkinsonism Relat Disord. 2022 May; 98:41-46 Epub 2022 Apr 14
    View PubMed
  10. Grijalva RM, Pham NTT, Huang Q, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Weigand SD, Ahlskog JE, Dickson DW, Josephs KA, Whitwell JL. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy. Mov Disord. 2022 Apr; 37 (4):702-712 Epub 2021 Dec 31
    View PubMed
  11. Chou CZ, Ahlskog JE, Klassen BT, Coon EA, Ali F, Bower JH, Savica R, Hassan A. Utility of routine surface electrophysiology to screen for functional tremor prior to surgical treatment of essential tremor. Clin Park Relat Disord. 2022; 7:100149 Epub 2022 June 16
    View PubMed
  12. Carlos AF, Tosakulwong N, Weigand SD, Buciuc M, Ali F, Clark HM, Botha H, Utianski RL, Machulda MM, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Ahlskog JE, Dickson DW, Josephs KA, Whitwell JL. Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies. Brain Commun. 2022; 4 (3):fcac108 Epub 2022 Apr 28
    View PubMed
  13. Clark HM, Tosakulwong N, Weigand SD, Ali F, Botha H, Pham NTT, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Lowe VJ, Ahlskog JE, Josephs KA, Whitwell JL. Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy. Mov Disord. 2021 Nov; 36 (11):2669-2675 Epub 2021 Aug 23
    View PubMed
  14. Whitwell JL, Tosakulwong N, Clark HM, Ali F, Botha H, Weigand SD, Sintini I, Machulda MM, Schwarz CG, Reid RI, Jack CR Jr, Ahlskog JE, Josephs KA. Diffusion tensor imaging analysis in three progressive supranuclear palsy variants. J Neurol. 2021 Sep; 268 (9):3409-3420 Epub 2021 Mar 12
    View PubMed
  15. Hassan A, Mittal SO, Hu WT, Josephs KA, Sorenson EJ, Ahlskog JE. Natural History of "Pure" Primary Lateral Sclerosis. Neurology. 2021 Apr 27; 96 (17):e2231-e2238 Epub 2021 Feb 26
    View PubMed
  16. Coon EA, Ahlskog JE. My Treatment Approach to Multiple System Atrophy. Mayo Clin Proc. 2021 Mar; 96 (3):708-719
    View PubMed
  17. Ahlskog JE. Common Myths and Misconceptions That Sidetrack Parkinson Disease Treatment, to the Detriment of Patients. Mayo Clin Proc. 2020 Oct; 95 (10):2225-2234
    View PubMed
  18. Hasan S, Mielke MM, Ahlskog JE, Bower J, Turcano P, Savica R. Infections or Sepsis Preceding Clinically Diagnosed alpha-Synucleinopathies: A Case-Control Study. Mov Disord. 2020 Sep; 35 (9):1684-1689 Epub 2020 June 01
    View PubMed
  19. Tisel SM, Ahlskog JE, Duffy JR, Matsumoto JY, Josephs KA. PSP-like syndrome after aortic surgery in adults (Mokri syndrome). Neurol Clin Pract. 2020 Jun; 10 (3):245-254
    View PubMed
  20. Turcano P, Stang CD, Bower JH, Ahlskog JE, Boeve BF, Mielke MM, Savica R. Levodopa-induced dyskinesia in dementia with Lewy bodies and Parkinson disease with dementia. Neurol Clin Pract. 2020 Apr; 10 (2):156-161
    View PubMed
  21. Hasan S, Mielke MM, Turcano P, Ahlskog JE, Bower JH, Savica R. Traumatic brain injury preceding clinically diagnosed alpha-synucleinopathies: A case-control study. Neurology. 2020 Feb 25; 94 (8):e764-e773 Epub 2020 Jan 28
    View PubMed
  22. Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin. 2020; 25:102152 Epub 2019 Dec 28
    View PubMed
  23. Stang CD, Turcano P, Mielke MM, Josephs KA, Bower JH, Ahlskog JE, Boeve BF, Martin PR, Upadhyaya SG, Savica R. Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study. J Parkinsons Dis. 2020; 10 (1):179-184
    View PubMed
  24. van Gerpen JA, Al-Shaikh RH, Tipton PW, Wszolek ZK, Uitti RJ, Ferman TJ, Dickson DW, Benarroch EE, Singer W, Cutsforth-Gregory JK, Heckman MG, Brushaber DE, Josephs KA, Low PA, Ahlskog JE, Cheshire WP. Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. Neurology. 2019 Oct 1; 93 (14):e1339-e1347 Epub 2019 Sept 04
    View PubMed
  25. Savica R, Turcano P, Bower JH, Ahlskog JE, Mielke MM. Survival and Progression in Synucleinopathy Phenotypes With Parkinsonism: A Population-Based Study. Mayo Clin Proc. 2019 Sep; 94 (9):1825-1831 Epub 2019 Aug 09
    View PubMed
  26. Jackson L, Coon EA, Ahlskog JE, Bower JH, Sandroni P, Benarroch EE, Mandrekar JN, Low PA, Singer W. Earlier age of onset in multiple system atrophy with smoking and heavy alcohol use. Parkinsonism Relat Disord. 2019 Sep; 66:212-215 Epub 2019 July 17
    View PubMed
  27. Sintini I, Schwarz CG, Senjem ML, Reid RI, Botha H, Ali F, Ahlskog JE, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Multimodal neuroimaging relationships in progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 Sep; 66:56-61. Epub 2019 Jul 02.
    View PubMed
  28. Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. Mov Disord. 2019 Aug; 34 (8):1144-1153 Epub 2019 Feb 06
    View PubMed
  29. Koga S, Eric Ahlskog J, DeTure MA, Baker M, Roemer SF, Konno T, Rademakers R, Ross OA, Dickson DW. Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1. J Neuropathol Exp Neurol. 2019 Aug 1; 78 (8):756-762
    View PubMed
  30. Coon EA, Nelson RM, Sletten DM, Suarez MD, Ahlskog JE, Benarroch EE, Sandroni P, Mandrekar JN, Low PA, Singer W. Sex and gender influence symptom manifestation and survival in multiple system atrophy. Auton Neurosci. 2019 Jul; 219:49-52. Epub 2019 Apr 24.
    View PubMed
  31. Hasan S, Mielke MM, Ahlskog JE, Bower J, Turcano P, Savica R. Erectile Dysfunction Preceding Clinically Diagnosed alpha-Synucleinopathies: A Case-Control Study in Olmsted County. Parkinsons Dis. 2019; 2019:6303945 Epub 2019 Apr 09
    View PubMed
  32. Whitwell JL, Tosakulwong N, Schwarz CG, Botha H, Senjem ML, Spychalla AJ, Ahlskog JE, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy. Mov Disord. 2019 Jan; 34 (1):105-113 Epub 2018 Nov 23
    View PubMed
  33. Turcano P, Mielke MM, Bower JH, Parisi JE, Cutsforth-Gregory JK, Ahlskog JE, Savica R. Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study. Neurology. 2018 Dec 11; 91 (24):e2238-e2243 Epub 2018 Nov 07
    View PubMed
  34. Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol. 2018 Sep; 136 (3):389-404 Epub 2018 June 20
    View PubMed
  35. Coon EA, Ahlskog JE, Silber MH, Fealey RD, Benarroch EE, Sandroni P, Mandrekar JN, Low PA, Singer W. Do selective serotonin reuptake inhibitors improve survival in multiple system atrophy? Parkinsonism Relat Disord. 2018 Mar; 48:51-53 Epub 2017 Dec 14
    View PubMed
  36. Whitwell JL, Ahlskog JE, Tosakulwong N, Senjem ML, Spychalla AJ, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy. Parkinsonism Relat Disord. 2018 Mar; 48:3-9 Epub 2017 Dec 13
    View PubMed
  37. Ahlskog JE. Aerobic Exercise: Evidence for a Direct Brain Effect to Slow Parkinson Disease Progression. Mayo Clin Proc. 2018 Mar; 93 (3):360-372
    View PubMed
  38. Ryan C, Ahlskog JE, Savica R. Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center. Parkinsonism Relat Disord. 2018 Mar; 48:97-100 Epub 2017 Dec 29
    View PubMed
  39. Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, Ahlskog JE, Uitti RJ, Graff-Radford N, van Gerpen JA, Wszolek ZK, Rademakers R, Dickson DW. Cognitive impairment in progressive supranuclear palsy is associated with tau burden. Mov Disord. 2017 Dec; 32 (12):1772-1779 Epub 2017 Oct 30
    View PubMed
  40. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Boeve BF, Graff-Radford J, Rocca WA, Mielke MM. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study. JAMA Neurol. 2017 Jul 1; 74 (7):839-846
    View PubMed
  41. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Mielke MM, Rocca WA. Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study. Mov Disord. 2017 Feb; 32 (2):227-234 Epub 2016 Oct 25
    View PubMed
  42. Janssen PH, Mandrekar J, Mielke MM, Ahlskog JE, Boeve BF, Josephs K, Savica R. High School Football and Late-Life Risk of Neurodegenerative Syndromes, 1956-1970. Mayo Clin Proc. 2017 Jan; 92 (1):66-71 Epub 2016 Dec 12
    View PubMed
  43. Owens E, Josephs KA, Savica R, Hassan A, Klassen B, Bower J, Maraganore D, Matsumoto J, Ahlskog JE. The clinical spectrum and natural history of pure akinesia with gait freezing. J Neurol. 2016 Dec; 263 (12):2419-2423 Epub 2016 Sept 13
    View PubMed
  44. Biernacka JM, Chung SJ, Armasu SM, Anderson KS, Lill CM, Bertram L, Ahlskog JE, Brighina L, Frigerio R, Maraganore DM. Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease. Parkinsonism Relat Disord. 2016 Nov; 32:25-30 Epub 2016 Aug 03
    View PubMed
  45. van Gerpen JA, Ahlskog JE, Chen R, Fung VS, Hallett M, Govert F, Deuschl G, Leypoldt F. Orthostatic myoclonus associated with Caspr2 antibodies. Neurology. 2016 Sep 13; 87: (11)1187-8.
    View PubMed
  46. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time Trends in the Incidence of Parkinson Disease. JAMA Neurol. 2016 Aug 1; 73 (8):981-9
    View PubMed
  47. Owens E, Krecke K, Ahlskog JE, Fealey R, Hassan A, Josephs KA, Klassen B, Matsumoto J, Bower J. Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy. Parkinsonism Relat Disord. 2016 Jul; 28:107-11 Epub 2016 May 03
    View PubMed
  48. Cutsforth-Gregory JK, Ahlskog JE, McKeon A, Burnett MS, Matsumoto JY, Hassan A, Bower JH. Repetitive exercise dystonia: A difficult to treat hazard of runner and non-runner athletes. Parkinsonism Relat Disord. 2016 Jun; 27:74-80.
    View PubMed
  49. Ahlskog JE. New and Appropriate Goals for Parkinson Disease Physical Therapy. JAMA Neurol 2016 Mar; 73 (3):269-70
    View PubMed
  50. Hassan A, Ahlskog JE, Matsumoto JY, Milber JM, Bower JH, Wilkinson JR. Orthostatic tremor: Clinical, electrophysiologic, and treatment findings in 184 patients. Neurology. 2016 Feb 2; 86 (5):458-64 Epub 2016 Jan 08
    View PubMed
  51. Coon EA, Ahlskog JE, Patterson MC, Niu Z, Milone M. Expanding Phenotypic Spectrum of NKX2-1-Related Disorders-Mitochondrial and Immunologic Dysfunction. JAMA Neurol. 2016 Feb; 73 (2):237-8
    View PubMed
  52. Hassan A, Heckman MG, Ahlskog JE, Wszolek ZK, Serie DJ, Uitti RJ, van Gerpen JA, Okun MS, Rayaprolu S, Ross OA. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. Parkinsonism Relat Disord. 2016 Jan; 22:102-5 Epub 2015 Nov 25
    View PubMed
  53. Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2 (6):e161 Epub 2015 Oct 01
    View PubMed
  54. Coon EA, Sletten DM, Suarez MD, Mandrekar JN, Ahlskog JE, Bower JH, Matsumoto JY, Silber MH, Benarroch EE, Fealey RD, Sandroni P, Low PA, Singer W. Clinical features and autonomic testing predict survival in multiple system atrophy. Brain. 2015 Dec; 138(Pt 12):3623-31. Epub 2015 Sep 13.
    View PubMed
  55. Labbe C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, Puschmann A, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Sanotsky Y, Rektorova I, McLean PJ, Rademakers R, Ertekin-Taner N, Hassan A, Ahlskog JE, Boeve BF, Petersen RC, Maraganore DM, Adler CH, Ferman TJ, Parisi JE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA. Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies. Neurology. 2015 Nov 10; 85 (19):1680-6 Epub 2015 Sept 02
    View PubMed
  56. Labbe C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, Puschmann A, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Sanotsky Y, Rektorova I, McLean PJ, Rademakers R, Ertekin-Taner N, Hassan A, Ahlskog JE, Boeve BF, Petersen RC, Maraganore DM, Adler CH, Ferman TJ, Parisi JE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA. "Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies": Correction Neurology. 2015 Nov; 85: (19)1728.
  57. Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, McKeon A. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults. JAMA Neurol. 2015 Nov; 72 (11):1304-12
    View PubMed
  58. Ahlskog JE. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls. Mayo Clin Proc. 2014 Jul; 89 (7):997-1003
    View PubMed
  59. Burnett MS, Witte RJ, Ahlskog JE. Swiss cheese striatum: clinical implications. JAMA Neurol. 2014 Jun; 71(6):735-41.
    View PubMed
  60. Markopoulou K, Biernacka JM, Armasu SM, Anderson KJ, Ahlskog JE, Chase BA, Chung SJ, Cunningham JM, Farrer M, Frigerio R, Maraganore DM. Does alpha-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease? Parkinsonism Relat Disord. 2014 Jun; 20 (6):584-9; discussion 584 Epub 2014 Mar 05
    View PubMed
  61. Clark HM, Duffy JR, Whitwell JL, Ahlskog JE, Sorenson EJ, Josephs KA. Clinical and imaging characterization of progressive spastic dysarthria. Eur J Neurol. 2014 Mar; 21 (3):368-76 Epub 2013 Sept 19
    View PubMed
  62. Figueroa JJ, Singer W, Parsaik A, Benarroch EE, Ahlskog JE, Fealey RD, Parisi JE, Sandroni P, Mandrekar J, Iodice V, Low PA, Bower JH. Multiple system atrophy: Prognostic indicators of survival. Mov Disord. 2014; 29(9):1151-7.
    View PubMed
  63. Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013 Nov; 70 (11):1396-402
    View PubMed
  64. Whitwell JL, Jack CR Jr, Parisi JE, Gunter JL, Weigand SD, Boeve BF, Ahlskog JE, Petersen RC, Dickson DW, Josephs KA. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol. 2013 Oct; 20 (10):1417-22 Epub 2013 June 07
    View PubMed
  65. Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, Dickson DW, Parisi J, Aakre JA, Geda YE, Knopman DS, Petersen RC, Boeve BF. Risk factors for dementia with Lewy bodies: a case-control study. Neurology. 2013 Aug 27; 81 (9):833-40 Epub 2013 July 26
    View PubMed
  66. Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, Santamaria J, Tolosa E, Singer C, Mash DC, Luca C, Arnulf I, Duyckaerts C, Schenck CH, Mahowald MW, Dauvilliers Y, Graff-Radford NR, Wszolek ZK, Parisi JE, Dugger B, Murray ME, Dickson DW. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013 Aug; 14 (8):754-62 Epub 2013 Mar 07
    View PubMed
  67. Parsaik AK, Ahlskog JE, Singer W, Gelfman R, Sheldon SH, Seime RJ, Craft JM, Staab JP, Kantor B, Low PA. Central hyperadrenergic state after lightning strike. Clin Auton Res. 2013 Aug; 23 (4):169-73 Epub 2013 June 13
    View PubMed
  68. Graff-Radford J, Rubin MN, Jones DT, Aksamit AJ, Ahlskog JE, Knopman DS, Petersen RC, Boeve BF, Josephs KA. The alien limb phenomenon. J Neurol. 2013 Jul; 260 (7):1880-8 Epub 2013 Apr 10
    View PubMed
  69. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol. 2013 Jul; 70 (7):859-66
    View PubMed
  70. Chung SJ, Armasu SM, Anderson KJ, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Ahlskog JE, Frigerio R, Maraganore DM. Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions. Parkinsonism Relat Disord. 2013 Jun; 19 (6):595-9 Epub 2013 Mar 16
    View PubMed
  71. O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A. Autoimmune chorea in adults. Neurology. 2013 Mar 19; 80 (12):1133-44 Epub 2013 Feb 20
    View PubMed
  72. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Risk factors for Parkinson's disease may differ in men and women: an exploratory study. Horm Behav. 2013 Feb; 63 (2):308-14 Epub 2012 June 08
    View PubMed
  73. Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012 Dec; 69(12):1598-607.
    View PubMed
  74. Graff-Radford J, Boeve BF, Drubach DA, Knopman DS, Ahlskog JE, Golden EC, Drubach DI, Petersen RC, Josephs KA. Limb immobilization and corticobasal syndrome. Parkinsonism Relat Disord. 2012 Dec; 18 (10):1097-9 Epub 2012 June 20
    View PubMed
  75. Hassan A, Mateen FJ, Coon EA, Ahlskog JE. Painful legs and moving toes syndrome: a 76-patient case series. Arch Neurol. 2012 Aug; 69(8):1032-8.
    View PubMed
  76. Chung SJ, Armasu SM, Biernacka JM, Anderson KJ, Lesnick TG, Rider DN, Cunningham JM, Eric Ahlskog J, Frigerio R, Maraganore DM. Genomic determinants of motor and cognitive outcomes in Parkinson's disease. Parkinsonism Relat Disord. 2012 Aug; 18 (7):881-6 Epub 2012 May 30
    View PubMed
  77. Savica R, Grossardt BR, Ahlskog JE, Rocca WA. Metabolic markers or conditions preceding Parkinson's disease: a case-control study. Mov Disord. 2012 Jul; 27 (8):974-9 Epub 2012 June 01
    View PubMed
  78. Kimpinski K, Iodice V, Burton DD, Camilleri M, Mullan BP, Lipp A, Sandroni P, Gehrking TL, Sletten DM, Ahlskog JE, Fealey RD, Singer W, Low PA. The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci. 2012 Jun 15; 317(1-2):92-6. Epub 2012 Mar 14.
    View PubMed
  79. Hassan A, Ahlskog JE, Rodriguez M, Matsumoto JY. Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study. Eur J Neurol. 2012 May; 19 (5):764-8 Epub 2012 Jan 17
    View PubMed
  80. Savica R, Parisi JE, Wold LE, Josephs KA, Ahlskog JE. High school football and risk of neurodegeneration: a community-based study. Mayo Clin Proc. 2012 Apr; 87 (4):335-40
    View PubMed
  81. Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry. 2012 Apr; 83(4):453-9. Epub 2012 Jan 06.
    View PubMed
  82. Czarnecki K, Thompson JM, Seime R, Geda YE, Duffy JR, Ahlskog JE. Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord. 2012 Mar; 18 (3):247-51 Epub 2011 Nov 22
    View PubMed
  83. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012 Feb; 69 (2):230-8
    View PubMed
  84. Savica R, Kumar N, Ahlskog JE, Josephs KA, Matsumoto JY, McKeon A. Parkinsonism and dropped head: dystonia, myopathy or both? Parkinsonism Relat Disord. 2012 Jan; 18(1):30-4. Epub 2011 Aug 27.
    View PubMed
  85. Ahlskog JE. Cheaper, simpler, and better: tips for treating seniors with Parkinson disease. Mayo Clin Proc. 2011 Dec; 86 (12):1211-6
    View PubMed
  86. Biernacka JM, Armasu SM, Cunningham JM, Ahlskog JE, Chung SJ, Maraganore DM. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility? Parkinsonism Relat Disord. 2011 Dec; 17 (10):730-6 Epub 2011 Aug 03
    View PubMed
  87. Graff-Radford J, Whitwell JL, Trenerry MR, Ahlskog JE, Jensen MD, Jack CR Jr, Josephs KA. Focal brain atrophy in gastric bypass patients with cognitive complaints. J Clin Neurosci. 2011 Dec; 18 (12):1671-6 Epub 2011 Nov 15
    View PubMed
  88. Klassen BT, Ahlskog JE. Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology. 2011 Sep 20; 77 (12):1119-25 Epub 2011 Aug 17
    View PubMed
  89. Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc. 2011 Sep; 86 (9):876-84
    View PubMed
  90. Savica R, Matsumoto JY, Josephs KA, Ahlskog JE, Stead M, Lee KH, Klassen BT. Deep brain stimulation in benign tremulous parkinsonism. Arch Neurol. 2011 Aug; 68 (8):1033-6
    View PubMed
  91. Ahlskog JE. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease. Physiol Behav. 2011 Jul 25; 104 (1):168-72 Epub 2011 May 05
    View PubMed
  92. Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology. 2011 Jul 19; 77 (3):288-94
    View PubMed
  93. Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord. 2011 May; 17 (4):260-4 Epub 2011 Feb 09
    View PubMed
  94. Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, DelleDonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging. 2011 May; 32 (5):857-63 Epub 2009 June 26
    View PubMed
  95. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. "Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images": Correction. Arch Neurol. 2011 Mar; 68(3):371.
  96. Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE. Corrigendum to "Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies" [Parkinsonism Relat Disord 17 (2011) 260-264]. Parkinsonism Relat Disord. 2011; 17(6):499.
  97. Ahlskog JE. Seniors with Parkinson's disease: initial medical treatment. J Clin Neurol. 2010 Dec; 6 (4):159-66 Epub 2010 Dec 31
    View PubMed
  98. Graff-Radford J, Ahlskog JE, Bower JH, Josephs KA. Dopamine agonists and Othello's syndrome. Parkinsonism Relat Disord. 2010 Dec; 16 (10):680-2 Epub 2010 Sept 09
    View PubMed
  99. Whitwell JL, Jack CR Jr, Boeve BF, Parisi JE, Ahlskog JE, Drubach DA, Senjem ML, Knopman DS, Petersen RC, Dickson DW, Josephs KA. Imaging correlates of pathology in corticobasal syndrome. Neurology. 2010 Nov 23; 75 (21):1879-87
    View PubMed
  100. Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, Colligan RC, Geda YE, Therneau TM, Rocca WA. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord. 2010 Oct 15; 25 (13):2105-13
    View PubMed
  101. Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. 2010 Aug 10; 75 (6):494-9 Epub 2010 July 28
    View PubMed
  102. Arabia G, Grossardt BR, Colligan RC, Bower JH, Maraganore DM, Ahlskog JE, Geda YE, Rocca WA. Novelty seeking and introversion do not predict the long-term risk of Parkinson disease. Neurology. 2010 Jul 27; 75 (4):349-57
    View PubMed
  103. Savica R, Rocca WA, Ahlskog JE. When does Parkinson disease start? Arch Neurol. 2010 Jul; 67 (7):798-801
    View PubMed
  104. Ahlskog JE, Uitti RJ. Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction? Neurology. 2010 Apr 6; 74 (14):1143-8
    View PubMed
  105. Ahlskog JE. Pearls: parkinsonism. Semin Neurol. 2010 Feb; 30(1):10-4. Epub 2010 Feb 01.
    View PubMed
  106. Ahlskog JE. Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec; 15 (10):721-7 Epub 2009 Oct 07
    View PubMed
  107. Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S1-5
    View PubMed
  108. Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA. Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology. 2009 Nov 24; 73 (21):1752-8
    View PubMed
  109. Savica R, Grossardt BR, Carlin JM, Icen M, Bower JH, Ahlskog JE, Maraganore DM, Steensma DP, Rocca WA. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology. 2009 Oct 27; 73 (17):1381-7
    View PubMed
  110. Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE. Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol. 2009 Sep; 66 (9):1114-9
    View PubMed
  111. Orr CF, Ahlskog JE. Frequency, characteristics, and risk factors for amiodarone neurotoxicity. Arch Neurol. 2009 Jul; 66 (7):865-9
    View PubMed
  112. Lipp A, Sandroni P, Ahlskog JE, Fealey RD, Kimpinski K, Iodice V, Gehrking TL, Weigand SD, Sletten DM, Gehrking JA, Nickander KK, Singer W, Maraganore DM, Gilman S, Wenning GK, Shults CW, Low PA. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol. 2009 Jun; 66(6):742-50.
    View PubMed
  113. Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc. 2009 Apr; 84 (4):310-6
    View PubMed
  114. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol. 2009 Feb; 66(2):268-71.
    View PubMed
  115. Josephs KA, Ahlskog JE, Parisi JE, Boeve BF, Crum BA, Giannini C, Petersen RC. Rapidly progressive neurodegenerative dementias. Arch Neurol. 2009 Feb; 66 (2):201-7
    View PubMed
  116. McKeon A, Ahlskog JE, Bower JH, Josephs KA, Matsumoto JY. Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease. Mov Disord. 2009 Jan 15; 24(1):72-6.
    View PubMed
  117. McKeon A, Matsumoto JY, Bower JH, Ahlskog JE. The spectrum of disorders presenting as adult-onset focal lower extremity dystonia. Parkinsonism Relat Disord. 2008 Dec; 14(8):613-9. Epub 2008 Mar 07.
    View PubMed
  118. Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG. Antiphospholipid antibody-associated chorea. J Rheumatol. 2008 Nov; 35 (11):2165-70 Epub 2008 Oct 15
    View PubMed
  119. Fujishiro H, Ahn TB, Frigerio R, DelleDonne A, Josephs KA, Parisi JE, Eric Ahlskog J, Dickson DW. Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy? Acta Neuropathol. 2008 Sep; 116 (3):269-75 Epub 2008 June 14
    View PubMed
  120. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol. 2008 Aug; 65 (8):1074-80
    View PubMed
  121. Fujishiro H, Frigerio R, Burnett M, Klos KJ, Josephs KA, Delledonne A, Parisi JE, Ahlskog JE, Dickson DW. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord. 2008 Jun 15; 23 (8):1085-92
    View PubMed
  122. McKeon A, Ahlskog JE, Matsumoto JY. Psychogenic tremor occurring after deep brain stimulation surgery for essential tremor. Neurology. 2008 Apr 15; 70(16 Pt 2):1498-9.
    View PubMed
  123. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol. 2008 Apr; 115 (4):437-44 Epub 2008 Feb 09
    View PubMed
  124. Lesnick TG, Sorenson EJ, Ahlskog JE, Henley JR, Shehadeh L, Papapetropoulos S, Maraganore DM. Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway. PLoS One. 2008 Jan 16; 3 (1):e1449
    View PubMed
  125. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology. 2008 Jan 15; 70 (3):200-9 Epub 2007 Aug 29
    View PubMed
  126. McKeon A, Josephs KA, Klos KJ, Hecksel K, Bower JH, Michael Bostwick J, Eric Ahlskog J. Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2007 Dec; 13(8):516-9. Epub 2007 Jun 04.
    View PubMed
  127. Arabia G, Grossardt BR, Geda YE, Carlin JM, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry. 2007 Dec; 64 (12):1385-92
    View PubMed
  128. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007 Nov; 130(Pt 11):2770-88. Epub 2007 Apr 05.
    View PubMed
  129. Ahlskog JE. Beating a dead horse: dopamine and Parkinson disease. Neurology. 2007 Oct 23; 69(17):1701-11.
    View PubMed
  130. Hu WT, Parisi JE, Knopman DS, Boeve BF, Dickson DW, Ahlskog JE, Petersen RC, Josephs KA. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21(4):S39-43.
    View PubMed
  131. Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, Schaid DJ, Maraganore DM. Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol. 2007 Oct; 64 (10):1458-64
    View PubMed
  132. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007 Sep 11; 69 (11):1074-83 Epub 2007 Aug 29
    View PubMed
  133. McKeon A, Pittock SJ, Glass GA, Josephs KA, Bower JH, Lennon VA, Ahlskog JE. Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol. 2007 Sep; 64 (9):1318-22
    View PubMed
  134. Kumar N, McKeon A, Rabinstein AA, Kalina P, Ahlskog JE, Mokri B. Superficial siderosis and csf hypovolemia: the defect (dural) in the link. Neurology. 2007 Aug 28; 69(9):925-6.
    View PubMed
  135. Kumar N, McKeon A, Rebinstein, AA, Kalina P, Ahlskog JE, Mokri B. Clinical/Scientific Notes. Neurology 69 AAN Enterprises.. 2007 Aug 27;
  136. Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, Schaid DJ, Maraganore DM. Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov Disord. 2007 Aug 15; 22(11):1607-14.
    View PubMed
  137. Rocca W, Bower J, Ahlskog JE. Increased Risk of Essnetial Tremor in First-Degree Relatives of Patients with Parkinson's disease. Movement Disorders. 2007 Aug 15; 22:1607-1614.
  138. Lipp A, Sandroni P, Ahlskog JE, Maraganore DM, Shults CW, Low PA. Calf venous compliance in multiple system atrophy. Am J Physiol Heart Circ Physiol. 2007 Jul; 293 (1):H260-5 Epub 2007 Mar 02
    View PubMed
  139. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 2007 Jun; 3 (6):e98
    View PubMed
  140. Glass GA, Ahlskog JE, Matsumoto JY. Orthostatic myoclonus: a contributor to gait decline in selected elderly. Neurology. 2007 May 22; 68(21):1826-30. Epub 2007 Mar 14.
    View PubMed
  141. Frigerio R, Breteler MM, de Lau LM, Sanft KR, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Maraganore DM, Rocca WA. Number of children and risk of Parkinson's disease. Mov Disord. 2007 Apr 15; 22(5):632-9.
    View PubMed
  142. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog EJ, Smith GE, Caselli RC, Tippmann-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, DelTredici K, Braak H. Pathophysiology of REM Sleep Beaviour Disorder and Relevance to Neurodegenerative Disease. Brain. 2007 Apr.
  143. Frigerrio R, Glass G, Klos K, Ahlskog J. Do Incidental Lewy Body Disease (ILBD) and Parkinson's disease (PD) Have Similar Risk Factor Profiles? An Exploratory Study. Neurology. 2007 Mar 20; 68(Suppl 1):A259.
  144. Frigerio R, Glass GA, Klos KJ, Schneider NK, Josephs KA, Dickson DW, Apaydin H, Parisi JE, Boeve BF, Ahlskog JE. An Exploratory Study of Estrogen-Related Factors, Incidental Lewy Body Disease (ILB). Neurodegenerative Diseases. 2007; 4(Suppl 1):198.
  145. Boeve BF, Dickson DW, Olson EJ, Shepard JW, Silber MH, Ferman TJ, Ahlskog JE, Benarroch EE. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med. 2007 Jan; 8 (1):60-4 Epub 2006 Dec 06
    View PubMed
  146. Klos KJ, Ahlskog JE, Kumar N, Cambern S, Butz J, Burritt M, Fealey RD, Cowl CT, Parisi JE, Josephs KA. Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology. 2006 Dec 12; 67(11):1984-9.
    View PubMed
  147. Mokri B, Ahlskog JE, Luetmer PH. Chorea as a manifestation of spontaneous CSF leak. Neurology. 2006 Oct 24; 67(8):1490-1.
    View PubMed
  148. Klos KJ, Chandler M, Kumar N, Ahlskog JE, Josephs KA. Neuropsychological profiles of manganese neurotoxicity. Eur J Neurol. 2006 Oct; 13(10):1139-41.
    View PubMed
  149. Frigerio R, Sanft KR, Grossardt BR, Peterson BJ, Elbaz A, Bower JH, Ahlskog JE, de Andrade M, Maraganore DM, Rocca WA. Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord. 2006 Oct; 21(10):1688-92.
    View PubMed
  150. Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006 Sep; 81 (9):1207-14
    View PubMed
  151. Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology. 2006 Aug 8; 67(3):494-6.
    View PubMed
  152. Glass GA, Josephs KA, Ahlskog JE. Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. Arch Neurol. 2006 Jul; 63(7):978-81.
    View PubMed
  153. McDonnell SK, Schaid DJ, Elbaz A, Strain KJ, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA. Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study. Ann Neurol. 2006 May; 59 (5):788-95
    View PubMed
  154. Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, DiMauro S. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol. 2006 May; 59(5):859-62.
    View PubMed
  155. Kumar N, Cohen-Gadol AA, Wright RA, Miller GM, Piepgras DG, Ahlskog JE. Superficial siderosis. Neurology. 2006 Apr 25; 66(8):1144-52.
    View PubMed
  156. Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF, DeLucia MW, Dickson DW. Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology. 2006 Apr 11; 66(7):1100-2.
    View PubMed
  157. Josephs KA, Matsumoto JY, Ahlskog JE. Benign tremulous parkinsonism. Arch Neurol. 2006 Mar; 63(3):354-7.
    View PubMed
  158. Van Gerpen JA, Kumar N, Bower JH, Weigand S, Ahlskog JE. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Arch Neurol. 2006 Feb; 63(2):205-9.
    View PubMed
  159. Kumar N, Ahlskog JE, Klein CJ, Port JD. Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiology. 2006 Feb; 48 (2):78-83 Epub 2005 Oct 28
    View PubMed
  160. Rocca WA, Grossardt BR, Peterson BJ, Bower JH, Trenerry MR, Ahlskog JE, Sanft KR, de Andrade M, Maraganore DM. The Mayo Clinic cohort study of personality and aging: design and sampling, reliability and validity of instruments, and baseline description. Neuroepidemiology. 2006; 26(3):119-29. Epub 2006 Jan 17.
    View PubMed
  161. Frigerio R, Elbaz A, Sanft KR, Peterson BJ, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Maraganore DM, Rocca WA. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology. 2005 Nov 22; 65 (10):1575-83
    View PubMed
  162. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2005 Sep; 11 (6):381-6
    View PubMed
  163. Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol. 2005 Sep; 62(9):1385-90.
    View PubMed
  164. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol. 2005 Sep; 62 (9):1377-81 Epub 2005 July 11
    View PubMed
  165. Kumar N, Elliott MA, Hoyer JD, Harper CM Jr, Ahlskog JE, Phyliky RL. "Myelodysplasia," myeloneuropathy, and copper deficiency. Mayo Clin Proc. 2005 Jul; 80(7):943-6.
    View PubMed
  166. Hu WT, Josephs KA, Ahlskog JE, Shin C, Boeve BF, Witte RJ. MRI correlates of alien leg-like phenomenon in corticobasal degeneration. Mov Disord. 2005 Jul; 20(7):870-3.
    View PubMed
  167. Josephs KA, Ahlskog JE, Klos KJ, Kumar N, Fealey RD, Trenerry MR, Cowl CT. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology. 2005 Jun 28; 64(12):2033-9. Epub 2005 May 11.
    View PubMed
  168. Facheris M, Strain KJ, Lesnick TG, de Andrade M, Bower JH, Ahlskog JE, Cunningham JM, Lincoln S, Farrer MJ, Rocca WA, Maraganore DM. UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study. Neurosci Lett. 2005 Jun 10-17; 381(1-2):131-4. Epub 2005 Feb 25.
    View PubMed
  169. Elbaz A, Peterson BJ, Bower JH, Yang P, Maraganore DM, McDonnell SK, Ahlskog JE, Rocca WA. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study. Mov Disord. 2005 Jun; 20(6):719-25.
    View PubMed
  170. Mamah CE, Lesnick TG, Lincoln SJ, Strain KJ, de Andrade M, Bower JH, Ahlskog JE, Rocca WA, Farrer MJ, Maraganore DM. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Ann Neurol. 2005 Mar; 57(3):439-43.
    View PubMed
  171. Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord. 2005 Mar; 20(3):342-4.
    View PubMed
  172. Ahlskog JE. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease. Mov Disord. 2005 Mar; 20(3):271-82.
    View PubMed
  173. Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 Jan 25; 64(2):208-15.
    View PubMed
  174. Rocca WA, Peterson BJ, McDonnell SK, Bower JH, Ahlskog JE, Schaid DJ, Maraganore DM. The Mayo Clinic Family Study of Parkinson's disease: Study design, instruments, and sample characteristics. Neuroepidemiology. 2005; 24(3):151-67.
    View PubMed
  175. Kumar N, Ahlskog JE, Gross JB Jr. Acquired hypocupremia after gastric surgery. Clin Gastroenterol Hepatol. 2004 Dec; 2 (12):1074-9
    View PubMed
  176. Rocca WA, McDonnell SK, Strain KJ, Bower JH, Ahlskog JE, Elbaz A, Schaid DJ, Maraganore DM. Familial aggregation of Parkinson's disease: The Mayo Clinic family study. Ann Neurol. 2004 Oct; 56(4):495-502.
    View PubMed
  177. Maraganore DM, Wilkes K, Lesnick TG, Strain KJ, de Andrade M, Rocca WA, Bower JH, Ahlskog JE, Lincoln S, Farrer MJ. A limited role for DJ1 in Parkinson disease susceptibility. Neurology. 2004 Aug 10; 63(3):550-3.
    View PubMed
  178. Kumar N, Gross JB Jr, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology. 2004 Jul 13; 63 (1):33-9
    View PubMed
  179. Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord. 2004 Jun; 19(6):695-9.
    View PubMed
  180. Kumar N, Crum B, Petersen RC, Vernino SA, Ahlskog JE. Copper deficiency myelopathy. Arch Neurol. 2004 May; 61(5):762-6.
    View PubMed
  181. Mokri B, Ahlskog JE, Fulgham JR, Matsumoto JY. Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. Neurology. 2004 Mar 23; 62 (6):971-3
    View PubMed
  182. Kumar N, McEvoy KM, Ahlskog JE. Myelopathy due to copper deficiency following gastrointestinal surgery. Arch Neurol. 2003 Dec; 60(12):1782-5.
    View PubMed
  183. Blake ML, Duffy JR, Boeve BF, Ahlskog JE, Maraganore DM. Speech and language disorders associated with corticobasal degeneration. J Med Speech Lang Pathol. 2003 Sep; 11(3):131-46.
  184. Van Gerpen JA, Ahlskog JE, Petty GW. Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord. 2003 Aug; 9 (6):367-9
    View PubMed
  185. Kumar N, Gross JB Jr, Ahlskog JE. Myelopathy due to copper deficiency. Neurology. 2003 Jul 22; 61 (2):273-4
    View PubMed
  186. Elbaz A, McDonnell SK, Maraganore DM, Strain KJ, Schaid DJ, Bower JH, Ahlskog JE, Rocca WA. Validity of family history data on PD: evidence for a family information bias. Neurology. 2003 Jul 8; 61 (1):11-7
    View PubMed
  187. Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology. 2003 Jul 8; 61 (1):40-5
    View PubMed
  188. Ahlskog JE. Parkinson's disease: is the initial treatment established? Curr Neurol Neurosci Rep. 2003 Jul; 3 (4):289-95
    View PubMed
  189. Cohen-Gadol AA, Ahlskog JE, Matsumoto JY, Swenson MA, McClelland RL, Davis DH. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg. 2003 Jun; 98(6):1247-54.
    View PubMed
  190. Bower JH, Maraganore DM, Peterson BJ, McDonnell SK, Ahlskog JE, Rocca WA. Head trauma preceding PD: a case-control study. Neurology. 2003 May 27; 60 (10):1610-5
    View PubMed
  191. Ahlskog JE. Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology. 2003 Feb 11; 60 (3):381-9
    View PubMed
  192. Nausieda PA, Ahlskog JE. Agonists the New Initial PD Treatment? Practical Neurology. 2003 Jan; 57-63
  193. Elbaz A, Bower JH, Peterson BJ, Maraganore DM, McDonnell SK, Ahlskog JE, Schaid DJ, Rocca WA. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol. 2003 Jan; 60 (1):91-6
    View PubMed
  194. Elbaz A, Peterson BJ, Yang P, Van Gerpen JA, Bower JH, Maraganore DM, McDonnell SK, Ahlskog JE, Rocca WA. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology. 2002 Mar; 13 (2):157-64
    View PubMed
  195. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol. 2002 Jan; 59(1):102-12.
    View PubMed
  196. Elbaz A, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol. 2002 Jan; 55 (1):25-31
    View PubMed
  197. Matsumoto J, Morrow D, Matsumoto J, Morrow D, Kaufman K, Davis D, Kaufman K, Davis D, Ahlskog JE, Walker A, Sneve D, Noseworthy J, Rodriguez M, Noseworthy J, Rodriguez M. Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology. 2001 Nov 27; 57 (10):1876-82
    View PubMed
  198. Tsuboi Y, Ahlskog JE, Apaydin H, Parisi JE, Dickson DW. Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls. Neurology. 2001 Nov 13; 57 (9):1675-8
    View PubMed
  199. Benedetti MD, Maraganore DM, Bower JH, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord. 2001 Sep; 16 (5):830-7
    View PubMed
  200. Ahlskog JE, Nishino H, Evidente VG, Tulloch JW, Evidente VG, Forbes GS, Caviness JN, Gwinn-Hardy KA. Persistent chorea triggered by hyperglycemic crisis in diabetics. Mov Disord. 2001 Sep; 16 (5):890-8
    View PubMed
  201. Ahlskog JE. Parkinson's disease: medical and surgical treatment. Neurol Clin. 2001 Aug; 19 (3):579-605, vi
    View PubMed
  202. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001 May; 16 (3):448-58
    View PubMed
  203. Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology. 2000 Nov 14; 55 (9):1350-8
    View PubMed
  204. Ahlskog JE. Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism. Parkinsonism Relat Disord. 2000 Nov 1; 7 (1):63-70
    View PubMed
  205. Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG. Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve. 2000 Nov; 23 (11):1752-6
    View PubMed
  206. Ahlskog JE. Treatment of motor complications in advancing Parkinson's disease: which drugs and when? Formulary. 2000 Aug; 35(8):654-658.
  207. Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord. 2000 Jul; 15 (4):669-77
    View PubMed
  208. Wright RA, Ahlskog JE. Focal shoulder-elevation dystonia. Mov Disord. 2000 Jul; 15 (4):709-13
    View PubMed
  209. Beran-Koehn MA, Zupanc ML, Patterson MC, Olk DG, Ahlskog JE. Violent recurrent ballism associated with infections in two children with static encephalopathy. Mov Disord. 2000 May; 15: (3)570-4.
    View PubMed
  210. Hurt RD, Ahlskog JE, Croghan GA, Offord KP, Wolter TD, Croghan IT, Moyer TP. Carbidopa/levodopa for smoking cessation: a pilot study with negative results. Nicotine Tob Res. 2000 Feb; 2 (1):71-8
    View PubMed
  211. Ahlskog JE, Uitti R, O'Connor M, Maraganore D, et al. The Effect of Dopamine Agonist Therapy on Dopamine Transporter Imaging in Parkinson's Disease. Focus on Parkinson's Disease. 2000; 12(3):74-5.
  212. Ahlskog JE. Medical treatment of later-stage motor problems of Parkinson disease. Mayo Clin Proc. 1999 Dec; 74 (12):1239-54
    View PubMed
  213. Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord. 1999 Nov; 14 (6):940-6
    View PubMed
  214. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, Dickson DW, Kokmen E, Petersen RC. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999 Sep 11; 53 (4):795-800
    View PubMed
  215. Perez-Tur J, Buee L, Morris HR, Waring SC, Onstead L, Wavrant-De Vrieze F, Crook R, Buee-Scherrer V, Hof PR, Petersen RC, McGeer PL, Delacourte A, Hutton M, Siddique T, Ahlskog JE, Hardy J, Steele JC. Neurodegenerative diseases of Guam: analysis of TAU. Neurology. 1999 Jul 22; 53 (2):411-3
    View PubMed
  216. Ahlskog JE, Litchy WJ, Peterson RC, Waring SC, Esteban-Santillan C, Chen KM, Harper CM, Craig UK, Kurland LT. Guamanian neurodegenerative disease: electrophysiologic findings. J Neurol Sci. 1999 Jun 15; 166 (1):28-35
    View PubMed
  217. Ling LH, Ahlskog JE, Munger TM, Limper AH, Oh JK. Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease. Mayo Clin Proc. 1999 Apr; 74 (4):371-5
    View PubMed
  218. Agid Y, Ahlskog JE, Albanese A, Calne D, et al. Levodopa in the Treatment of Parkinson's Disease: A Consensus Meeting. Movement Disorders. 1999; 14(6):911-3.
    View PubMed
  219. Ahlskog JE, Waring SC, Petersen RC, Esteban-Santillan C, Craig UK, O'Brien PC, Plevak MF, Kurland LT. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology. 1998 Dec; 51 (6):1672-7
    View PubMed
  220. Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease. Mov Disord. 1998 Sep; 13(5):782-7.
    View PubMed
  221. Chabolla DR, Maraganore DM, Ahlskog JE, O'Brien PC, Rocca WA. Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota. Mayo Clin Proc. 1998 Aug; 73(8):724-7.
    View PubMed
  222. Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 1998 Jul; 55(7):957-61.
    View PubMed
  223. Moellentine C, Rummans T, Ahlskog JE, Harmsen WS, Suman VJ, O'Connor MK, Black JL, Pileggi T. Effectiveness of ECT in patients with parkinsonism. Journal of Neuropsychiatry & Clinical Neurosciences. 1998 Spring; 10(2):187-93.
    View PubMed
  224. Low PA, Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Kurland LT. Autonomic failure in Guamanian neurodegenerative disease. Neurology. 1997 Oct; 49 (4):1031-4
    View PubMed
  225. Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Craig UK, Maraganore DM, Lennon VA, Kurland LT. Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis? Neurology. 1997 May; 48 (5):1356-62
    View PubMed
  226. Kumar R, Maraganore DM, Ahlskog JE, Rodriguez M, Rodriguez M. Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone. Neurology. 1997 Mar; 48 (3):732-5
    View PubMed
  227. Koch LD, Cofield RH, Ahlskog JE. Total shoulder arthroplasty in patients with Parkinson's disease. J Shoulder Elbow Surg. 1997 Jan-Feb; 6 (1):24-8
    View PubMed
  228. Ahlskog JE. Treatment of early Parkinson's disease: are complicated strategies justified? Mayo Clin Proc. 1996 Jul; 71(7):659-70.
    View PubMed
  229. Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology. 1996 Jun; 46 (6):1551-6
    View PubMed
  230. Ahlskog JE, Wright KF, Muenter MD, Adler CH. Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect. Clin Neuropharmacol. 1996 Jun; 19 (3):202-12
    View PubMed
  231. Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. Intranasal apomorphine rescue therapy for parkinsonian "off" periods. Clin Neuropharmacol. 1996 Jun; 19(3):193-201.
    View PubMed
  232. Uitti RJ, Ahlskog JE. Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease. CNS Drugs. 1996 May; 5 (5):369-88
    View PubMed
  233. Hutton JT, Koller WC, Ahlskog JE, Pahwa R, Hurtig HI, Stern MB, Hiner BC, Lieberman A, Pfeiffer RF, Rodnitzky RL, Waters CH, Muenter MD, Adler CH, Morris JL. Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease. Neurology. 1996 Apr; 46(4):1062-5.
    View PubMed
  234. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, O'Brien JF, Nickander KK. Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease. Neurology. 1996 Mar; 46 (3):796-801
    View PubMed
  235. Ahlskog JE, Uitti RJ, Tyce GM, O'Brien JF, Petersen RC, Kokmen E. Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases. J Neurol Sci. 1996 Mar; 136 (1-2):162-8
    View PubMed
  236. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov Disord. 1995 Sep; 10 (5):566-73
    View PubMed
  237. Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology. 1995 Jul; 45 (7):1340-4
    View PubMed
  238. Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR. Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease. Neurology. 1995 Mar; 45 (3 Pt 1):443-7
    View PubMed
  239. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry. 1995 Feb; 58 (2):167-73
    View PubMed
  240. Ahlskog JE. Diagnostic steps for suspected Parkinson's disease. Contemp Intern Med. 1995 Jan; 7(1):22-30.
    View PubMed
  241. Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K. Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline. Arch Neurol. 1994 Dec; 51 (12):1236-41
    View PubMed
  242. Goetz CG, Stebbins GT, Shale HM, Lang AE, Chernik DA, Chmura TA, Ahlskog JE, Dorflinger EE. Utility of an objective dyskinesia rating scale for Parkinson's disease--interrater and intrarater reliability assessment. Mov Disord. 1994 Jul; 9:390-394.
    View PubMed
  243. Ahlskog JE. Treatment of Parkinson's disease. From theory to practice. Postgrad Med. 1994 Apr; 95(5):52-4, 57-8, 61-4 passim.
    View PubMed
  244. Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc. 1994 Feb; 69 (2):169-80
    View PubMed
  245. Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Shoulson I, Grimes JD, Jankovic J, Hoehn M, Markham, Duvoisin R, Reinmuth 0, Leonard, Ahlskog JE, Feldman R, Hersey L, Yahr M. A Multi-Center Double-Blind Placebo Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease. Movement Disorders. 1994; 9(1):40-7.
    View PubMed
  246. Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology. 1993 Oct; 43 (10):1918-26
    View PubMed
  247. Lieberman A, Imke S, Muenter M, Wheeler K, Ahlskog JE, Matsumoto JY, Maraganore DM, Wright KF, Schoenfelder J. Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa. Neurology. 1993 Oct; 43(10):1981-4.
    View PubMed
  248. Ahlskog JE. Cerebral transplantation for Parkinson's disease: current progress and future prospects. Mayo Clin Proc. 1993 Jun; 68 (6):578-91
    View PubMed
  249. Goldman S, Ahlskog JE. Posttraumatic cervical dystonia. Mayo Clin Proc. 1993 May; 68 (5):443-8
    View PubMed
  250. Ahlskog JE, Muenter MD, Bailey PA, Stevens PM. Dopamine Agonist Treatment of Fluctuating Parkinsonism: D-2 (Controlled-Release MK-458) vs Combined D-1 and D-2 (Pergolide). Parkinson/Alzheimer Digest. 1993; 3:10-1.
  251. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993 Jan; 50 (1):78-80
    View PubMed
  252. Auger RG, Litchy WJ, Cascino TL, Ahlskog JE. Hemimasticatory spasm: clinical and electrophysiologic observations. Neurology. 1992 Dec; 42 (12):2263-6
    View PubMed
  253. Goldman MS, Ahlskog JE, Kelly PJ. The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg. 1992 Jun; 76 (6):924-8
    View PubMed
  254. Ahlskog JE, Muenter MD, Bailey PA, Stevens PM. Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide) Arch Neurol. 1992 May; 49 (5):560-8
    View PubMed
  255. Maraganore DM, Folger WN, Swanson JW, Ahlskog JE. Movement disorders as sequelae of central pontine myelinolysis: report of three cases. Mov Disord. 1992; 7(2):142-8.
    View PubMed
  256. Ahlskog JE. Parkinson's Disease: Update on Pharmacologic Options to Slow Progression and Treat Symptoms. Hospital Formulary 1992 Feb; 27(2):146-63.
  257. Fox MW, Ahlskog JE, Kelly PJ. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. J Neurosurg. 1991 Nov; 75(5):723-30.
    View PubMed
  258. Stoddard SL, Tyce GM, Ahlskog JE, Zinsmeister AR, Nelson DK, Carmichael SW. Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla. Exp Neurol. 1991 Oct; 114(1):23-7.
    View PubMed
  259. Ahlskog JE, Richelson E, Nelson A, Kelly PJ, Okazaki H, Tyce GM, van Heerden JA, Stoddard SL, Carmichael SW. Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients. Ann Neurol. 1991 Aug; 30(2):185-91.
    View PubMed
  260. Sandroni P, Ahlskog JE, Fealey RD, Low PA. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res. 1991 Jun; 1 (2):147-55
    View PubMed
  261. Ahlskog JE, Muenter MD, Bailey PA, Miller PM. Parkinson's disease monotherapy with controlled-release MK-458 (PHNO): double-blind study and comparison to carbidopa/levodopa. Clin Neuropharmacol. 1991 Jun; 14 (3):214-27
    View PubMed
  262. Davis DH, Ahlskog JE, Litchy WJ, Root LM. Selective peripheral denervation for torticollis: preliminary results. Mayo Clin Proc. 1991 Apr; 66 (4):365-71
    View PubMed
  263. Koller WC, Block GA, Ahlskog JE, et al. Effect of MK-458 (HPMC) in Parkinson's Disease Previously Untreated with Dopaminergic Drugs: A Double-Blind, Placebo-Controlled Multicenter Study. Clin Neuropharmacol. 1991; 14:322-9.
    View PubMed
  264. Ahlskog JE. Parkinson's disease: new treatment strategies. Compr Ther. 1990 Dec; 16(12):41-6.
    View PubMed
  265. Yaksh TL, Carmichael SW, Stoddard SL, Tyce GM, Kelly PJ, Lucas D, Van Heerden JA, Ahlskog JE, Byer DE. Measurement of lumbar CSF levels of met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson's disease before and after autologous transplantation of adrenal medulla into the caudate nucleus. J Lab Clin Med. 1990 Mar; 115:346-351.
    View PubMed
  266. Ahlskog JE, Kelly PJ, van Heerden JA, Stoddard SL, Tyce GM, Windebank AJ, Bailey PA, Bell GN, Blexrud MD, Carmichael SW. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies. Mayo Clin Proc. 1990 Mar; 65 (3):305-28
    View PubMed
  267. Ahlskog JE, Wilkinson JM. New concepts in the treatment of Parkinson's disease. Am Fam Physician. 1990 Feb; 41(2):574-84.
    View PubMed
  268. Tyce GM, Ahlskog JE, Carmichael SW, Chritton SL, Stoddard SL, van Heerden JA, Yaksh TL, Kelly PJ. Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease. J Lab Clin Med. 1989 Aug; 114(2):185-92.
    View PubMed
  269. Ahlskog JE, Tyce GM, Kelly PJ, van Heerden JA, Stoddard SL, Carmichael SW. Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease. Exp Neurol. 1989 Aug; 105 (2):152-61
    View PubMed
  270. Stoddard SL, Ahlskog JE, Kelly PJ, Tyce GM, van Heerden JA, Zinsmeister AR, Carmichael SW. Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients. Exp Neurol. 1989 Jun; 104(3):218-22.
    View PubMed
  271. Stoddard SL, Tyce GM, Ahlskog JE, Zinsmeister AR, Carmichael SW. Decreased catecholamine content in parkinsonian adrenal medullae. Exp Neurol. 1989 Apr; 104(1):22-7.
    View PubMed
  272. Kelly PJ, Ahlskog JE, van Heerden JA, Carmichael SW, Stoddard SL, Bell GN. Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. Mayo Clin Proc. 1989 Mar; 64 (3):282-90
    View PubMed
  273. Ahlskog JE. Medical treatment of Parkinson's disease. Compr Ther. 1989 Mar; 15(3):53-9.
    View PubMed
  274. Muenter MD, Ahlskog JE, Bell G, McManis P. PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent. Neurology. 1988 Oct; 38 (10):1541-5
    View PubMed
  275. Ahlskog JE, Muenter MD. Treatment of Parkinson's disease with pergolide: a double-blind study. Mayo Clin Proc. 1988 Oct; 63 (10):969-78
    View PubMed
  276. Ahlskog JE, Muenter MD. Pergolide: long-term use in Parkinson's disease. Mayo Clin Proc. 1988 Oct; 63 (10):979-87
    View PubMed
  277. Ahlskog JE, Muenter MD, McManis PG, Bell GN, Bailey PA. Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease. Mayo Clin Proc. 1988 Sep; 63 (9):876-86
    View PubMed
  278. Golbe LI, Lieberman AN, Muenter MD, Ahlskog JE, Gopinathan G, Neophytides AN, Sun-Hoo Foo, Duvoisin RC. Deprenyl in the Treatment of Symptom Fluctuations in Advanced Parkinson's Disease. Clinical Neuropharmacology. 1988; 11(1):45-55.
    View PubMed
  279. Kelly PJ, Ahlskog JE, Goerss SJ, Daube JR, Duffy JR, Kall BA. Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease. Mayo Clin Proc. 1987 Aug; 62(8):655-64.
    View PubMed
  280. Routh LC, Black JL, Ahlskog JE. Parkinson's disease complicated by anxiety. Mayo Clin Proc. 1987 Aug; 62(8):733-5.
    View PubMed
  281. Ahlskog JE, Randall PK, Hernandez L, Hoebel BG. Diminished Amphetamine Anorexia and Enhanced Fenfluramine Anorexia After Midbrain 6-hydroxydopamine. Psychopharmacology. 1984; 82:118-21.
    View PubMed
  282. Ahlskog JE. Combination Phenobarbital/Phenytoin Treatment of Epilepsy, Applied Therapeutic Drug Monitoring, Vol. II. 1982 Mar.
  283. Ahlskog JE, O'Neill BP. Pseudotumor Cerebri. Annals of Internal Medicine. 1982; 97:249-56.
    View PubMed
  284. Baez LA, Ahlskog JE, Randall PK. Body Weight and Regulatory Deficits Following Unilateral Nigrostriatal Lesions. Brain Research. 1977 Sep; 3:467-76.
  285. Ahlskog JE. Feeding response to regulatory challenges after 6-hydroxydopamine injection into the brain noradrenergic pathways. Physiol Behav. 1976 Sep; 17(3):407-11.
    View PubMed
  286. Ahlskog JE, Randall PK, Hoebel BG. Hypothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons. Science. 1975; 190:399-401.
    View PubMed
  287. Ahlskog JE. Food intake and amphetamine anorexia after selective forebrain norepinephrine loss. Brain Res. 1974; 82:211-240.
    View PubMed
  288. Ahlskog JE, Hoebel BG. Overeating and obesity from damage to a noradrenergic system in the brain. Science. 1973 Oct 12; 182(108):166-9.
    View PubMed
  289. Rilling ME, Askew HR, Ahlskog JE, Kramer TJ. Aversive properties of the negative stimulus in a successive discrimination. J Exp Anal Behav. 1969; 12:917-932.
    View PubMed
PST-20217360